Skip to main content
Dryad

Implication of the myo-inositol pathway in behavioral alterations of infected threespine sticklebacks

Data files

Oct 18, 2022 version files 106.69 KB

Abstract

Threespine stickleback (Gasterosteus aculeatus) infected with the tapeworm Schistocephalus solidus display impairments in their anti-predator responses. They also have increased expression of the gene encoding the IMPase 1 enzyme in their brains, which is part of a key step in myo-inositol synthesis. IMPase 1 and myo-inositol levels are the targets of lithium treatment in patients with bipolar disorder. Although promising candidates, we do not know if IMPase 1 and myo-inositol are directly implicated in the changes in risky behaviors measured in Schistocephalus-infected fish. Understanding the molecular mechanisms directly or indirectly involved in these behavioral alterations is crucial to understand the evolution of host-parasite interactions. Here, we increased myo-inositol levels of uninfected fish and inhibited IMPase 1 activity in infected fish to test the prediction that it would decrease and increase their anti-predator behaviour, respectively. We found that uninfected fish with increased myo-inositol levels (by injecting exogenous myo-inositol or by inducing endogenous production using an osmotic challenge) did not decrease their anti-predator responses. However, infected fish treated with lithium chloride had some of their anti-predator behaviors restored, but not all. They spent less time swimming close to the surface, swam a shorter distance, had a higher latency to feed, and spent more time frozen after a predator attack. Our results suggest that the target of lithium treatment is implicated in the risky behaviors of infected fish and supports the idea that the parasite-associated alteration in behavior has a multifactorial nature.